Back to User profile » Prof. Dr. Mark Wilcox
Papers published by Prof. Dr. Mark Wilcox:
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M
ClinicoEconomics and Outcomes Research 2022, 14:149-161
Published Date: 18 March 2022
Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH
Infection and Drug Resistance 2018, 11:1959-1974
Published Date: 25 October 2018
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
Monaghan TM, Negm OH, MacKenzie B, Hamed MR, Shone CC, Humphreys DP, Acharya KR, Wilcox MH
Clinical and Experimental Gastroenterology 2017, 10:169-175
Published Date: 19 July 2017
Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm
Crowther GS, Wilcox MH
Infection and Drug Resistance 2015, 8:333-337
Published Date: 15 September 2015